课题基金 / 基金详情

Miami Clinical and Translational Science Institute

Miami Clinical and Translational Science Institute
迈阿密临床与转化科学研究所
批准号:
10708431
负责人:
Olveen Carrasquillo
金额:
$399.1万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-18 至 2030-06-30

项目摘要

项目成果

Olveen Carrasquillo的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 位于南佛罗里达(SoFL),迈阿密大学的临床和转化科学研究所的目标 (CTSI)是为了改善我们社区的健康,解决健康差距,促进健康公平。的 CTSI通过促进开发、演示和传播 科学和业务创新,提高效率,有效性和质量的临床和 翻译研究这是通过不同利益攸关方的双向参与实现的,包括 患者倡导者和社区合作者,以帮助确定差距,挑战和瓶颈, 翻译研究过程。作为回应,CTSI开发并测试了由开发者驱动的资源、工具, 和干预措施,最终促进那些被证明是 通过传播和实施工作取得成功。这项工作由三个主要因素决定: 1)SoFL的特点是在种族、民族、语言、文化和宗教方面的复杂和多方面的多样性, 移民身份、社会经济劣势和污名化。这种复杂性使得CTSI Hub 研究者探索难以在其他地方概念化和评价的研究问题; 2)CTSI 在其科学劳动力和研究中优先考虑多样性,公平性,包容性和可访问性(DEIA) 参与者;和3)CTSI有一个强大的,成功的和持续的记录真实的社区, 利益相关者的参与,促进多学科研究,可以成功地克服 复制现有不平等的翻译陷阱。CTSI的工作重点、活动范围和目标如下: 基于对这些因素及其相互复杂作用的理解。连同 CTSI将:1)支持创新资源的开发和传播, 服务,以提高整个翻译研究的质量,效率和有效性 研究范围; 2)促进旨在促进和加速研究的研究合作, 改善社区健康,解决健康差距,促进健康公平; 3)发展创新 培训计划,以支持团队科学为导向的CTS劳动力,从翻译科学家到临床 研究专业人员和主要利益相关者;以及4)支持CTS研究响应这些总体 目标.通过这些努力,CTSI期望在质量、安全、 其临床和转化企业的效率、有效性和信息量。CTSI将 在区域和国家一级广泛传播其获得的知识, 现在和将来。通过这样做,CTSI加速带来转化科学的好处(更多 有效的治疗、药物、设备、行为干预和医疗程序), 无论他们的身份或访问。 PHS 398/2590(Rev.06/09)
英文摘要
Project Summary Located in South Florida (SoFL), the goals of University of Miami’s Clinical and Translational Science Institute (CTSI) are to improve the health of our community, address health disparities, and promote health equity. The CTSI accomplishes these goals by catalyzing the development, demonstration, and dissemination of scientific and operational innovations that improve the efficiency, effectiveness, and quality of clinical and translational research. This is done through bidirectional engagement of diverse stakeholders, including patient advocates and community collaborators, to help identify gaps, challenges, and chokepoints in the translational research process. In response, the CTSI develops and test stakeholder-driven resources, tools, and interventions ultimately promoting the adoption and integration of those that are demonstrated to be successful, through dissemination and implementation efforts. This work is shaped by three primary factors: 1) SoFL is characterized by complex and multifaceted diversity with respect to race, ethnicity, language, immigrant status, socioeconomic disadvantage, and stigmatization. This complexity allows CTSI Hub investigators to explore research questions difficult to conceptualize and evaluate elsewhere; 2) CTSI prioritizes diversity, equity, inclusion, and accessibility (DEIA) in its scientific workforce and research participants; and 3) CTSI has a strong, successful and sustained record of authentic community and stakeholder engagement which facilitates multidisciplinary research that can successfully overcome the translational pitfall of replicating existing inequities. The CTSI’s focus, scope of activities and aims are grounded in an understanding of these factors and their complex interplay with one another. Together with diverse stakeholders, the CTSI will: 1) support the development and dissemination of innovative resources and services to increase the quality, efficiency, and effectiveness of research across the entire translational research spectrum; 2) promote research collaborations aimed at facilitating and accelerating research to improve community health, address health disparities, and promote health equity; 3) develop innovative training programs to support a team science-oriented CTS workforce, from translational scientists to clinical research professionals and key stakeholders; and 4) support CTS research responsive to these overarching goals. Through these efforts, the CTSI expects to achieve significant improvements in the quality, safety, efficiency, effectiveness, and informativeness of its Clinical and Translational Enterprise. The CTSI will then broadly disseminate its acquired knowledge regionally and nationally to maximize impact and opportunity, both now and in the future. By doing so, the CTSI accelerates bringing the benefits of translational science (more effective treatments, drugs, devices, behavioral interventions, and medical procedures) to all people, regardless of their identity or access. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular Research Empowerment Workforce
Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida
  • 批准号:
    10538749
  • 项目类别:
  • 资助金额:
    $70.41万
  • 财政年份:
    2022
  • 负责人:
    Olveen Carrasquillo
  • 依托单位:
Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida
  • 批准号:
    11002204
  • 项目类别:
  • 资助金额:
    $68.29万
  • 财政年份:
    2022
  • 负责人:
    Olveen Carrasquillo
  • 依托单位:
Community Engagement Core
海外基金